“Light-Enhanced Hypoxia-Responsive Nanocarrier for Dual Gene Editing in Breast Cancer Therapy”

https://pubmed.ncbi.nlm.nih.gov/38117037

This study developed a light-enhanced, hypoxia-responsive nanocarrier for targeted dual gene editing in breast cancer, enhancing photodynamic and immunotherapy by increasing hypoxia levels and remodeling immune microenvironments.